Restricted transgene expression in the brain with cell-type specific neuronal promoters

Human Gene Therapy Methods

Volumn 23, Issue 4, 2012, Pages 242-254

  Delzor, Aurélie ^a   Dufour, Noelle ^a   Petit, Fanny ^a   Guillermier, Martine ^a   Houitte, Diane ^a   Auregan, Gwennaelle ^a   Brouillet, Emmanuel ^a   Hantraye, Philippe ^a   Déglon, Nicole ^a,b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR 1; LENTIVIRUS VECTOR; NEURON SPECIFIC ENOLASE; PHOSPHOGLYCERATE KINASE; PREPROTACHYKININ; AMPA RECEPTOR; DLX5 PROTEIN, MOUSE; DOPAMINE 1 RECEPTOR; ENOLASE; GLUTAMATE DECARBOXYLASE 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; HOMEODOMAIN PROTEIN; PGK1 PROTEIN, MOUSE; PROTEIN PRECURSOR; TACHYKININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CELL SUBPOPULATION; CELL TYPE; CORPUS STRIATUM; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; HOMEOBOX; MALE; MOUSE; NEUROTROPISM; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; TRANSGENE; ANIMAL; BRAIN; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; BRAIN; GENES, REPORTER; GENETIC VECTORS; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HOMEODOMAIN PROTEINS; LENTIVIRUS; MALE; MICE; NEURONS; PHOSPHOGLYCERATE KINASE; PHOSPHOPYRUVATE HYDRATASE; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; RATS; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; TACHYKININS; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC;

EID: 84872241791     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.073     Document Type: Article

References (83)

1. Adra, C.N., Boer, P.H., and Mcburney, M.W. (1987). Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60, 65-74. (Pubitemid 18026830)
2. Bartz, S.R., and Vodicka, M.A. (1997). Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12, 337-342. (Pubitemid 27371258)
3. Benchoua, A., Trioulier, Y., Diguet, E., et al. (2008). Dopamine determines the vulnerability of striatal neurons to the Nterminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Hum Mol Genet 17, 1446-1456. (Pubitemid 351627341)
4. Birney, E., Stamatoyannopoulos, J.A., Dutta, A., et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816. (Pubitemid 46920138)
5. Blömer, U., Naldini, L., Kafri, T., et al. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649. (Pubitemid 27355322)
6. Borges, K., and Dingledine, R. (2001). Functional organization of the GluR1 glutamate receptor promoter. J Biol Chem 276, 25929-25938.
7. Brochier, C., Gaillard, M.C., Diguet, E., et al. (2008). Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in man and affected in disease models. Physiol Genomics 33, 170-179. (Pubitemid 351629525)
8. Burns, J.C., Friedmann, T., Driever, W., et al. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc.Natl. Acad.Sci.USA 90, 8033-8037. (Pubitemid 23260849)
9. Cannon, J.R., Sew, T., Montero, L., et al. (2011). Pseudotypedependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Exp Neurol. 228, 41-52.
10. Carter, M.S., and Krause, J.E. (1990). Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma. J Neurosci 10, 2203-2214.
11. Chiang, M.C., Chen, H.M., Lee, Y.H., et al. (2007). Dysregulation of C/EBP{alpha} by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum Mol Genet 16, 483-498.
12. Cobos, I., Calcagnotto, M.E., Vilaythong, A.J., et al. (2005). Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 8, 1059-1068. (Pubitemid 41061517)
13. Coil, D.A., and Miller, A.D. (2004). Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 78, 10920-10926. (Pubitemid 39299632)
14. Coil, D.A., and Miller, A.D. (2005). Enhancement of enveloped virus entry by phosphatidylserine. J Virol 79, 11496-11500. (Pubitemid 41170690)
15. Cronin, J., Zhang, X.Y., and Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5, 387-398. (Pubitemid 41052430)
16. De Almeida, L.P., Ross, C.A., Zala, D., et al. (2002). Lentiviralmediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 22, 3473-3483. (Pubitemid 37465753)
17. Déglon, N., Tseng, J.L., Bensadoun, J.C., et al. (2000). Selfinactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11, 179-190. (Pubitemid 30044050)
18. Desmaris, N., Bosch, A., Salaun, C., et al. (2001). Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol. Ther. 4, 149-156. (Pubitemid 32776507)
19. Donello, J.E., Loeb, J.E., and Hope, T.J. (1998). Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J.Virol. 72, 5085-5092. (Pubitemid 28215689)
20. Fitzsimons, H.L., Bland, R.J., and During, M.J. (2002). Promoters and regulatory elements that improve adenoassociated virus transgene expression in the brain. Methods 28, 227-236. (Pubitemid 35341086)
21. Forss-Petter, S., Danielson, P.E., Catsicas, S., et al. (1990). Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5, 187-197. (Pubitemid 20262697)
22. Franklin, B., and Paxinos, G. (1996). The Mouse Brain in Stereotaxic Coordinates. (Academic Press: New York). 1-350.
23. Fremeau, R.T., Jr., Duncan, G.E., Fornaretto, M.G., et al. (1991). Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci USA 88, 3772-3776. (Pubitemid 21916706)
24. Galvan, L., Lepejova, N., Gaillard, M.C., et al. (2012). Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiol Aging 33, 1845 e5-6.
25. Gerfen, C.R. (1992). The neostriatal mosaic: multiple levels of compartmental organization. TINS 15, 133-138.
26. Ginn, S.L., Fleming, J., Rowe, P.B., et al. (2003). Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner. Hum Gene Ther 14, 1127-1137. (Pubitemid 36930403)
27. Gong, S., Zheng, C., Doughty, M.L., et al. (2003). A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425, 917-925. (Pubitemid 37376918)
28. Gruh, I., Wunderlich, S., Winkler, M., et al. (2008). Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors. J Gene Med 10, 21-32.
29. Gu, X., Andre, V.M., Cepeda, C., et al. (2007). Pathological cellcell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegener 2, 8.
30. Han, I., You, Y., Kordower, J.H., et al. (2010). Differential vulnerability of neurons in Huntington's disease: The role of cell type-specific features. J Neurochem 113, 1073-1091.
31. Hioki, H., Kameda, H., Nakamura, H., et al. (2007). Efficient gene transduction of neurons by lentivirus with enhanced neuronspecific promoters. Gene Ther 14, 872-882. (Pubitemid 46780070)
32. Hodges, A., Strand, A.D., Aragaki, A.K., et al. (2006). Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15, 965-977. (Pubitemid 43338237)
33. Hottinger, A.F., Azzouz, M., Déglon, N., et al. (2000). Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci 20, 5587-5593. (Pubitemid 30636884)
34. Hsiao, H.Y., and Chern, Y. (2010). Targeting Glial Cells to Elucidate the Pathogenesis of Huntington's Disease. Mol Neurobiol 41, 248-255.
35. Jinno, S., Aika, Y., Fukuda, T., and Kosaka, T. (1998). Quantitative analysis of GABAergic neurons in the mouse hippocampus, with optical disector using confocal laser scanning microscope. Brain Research 814, 55-70. (Pubitemid 29023411)
36. Jones, A.R., Overly, C.C., and Sunkin, S.M. (2009). The Allen Brain Atlas: 5 years and beyond. Nat Rev Neurosci 10, 821-828.
37. Katarova, Z., Mugnaini, E., Sekerkova, G., et al. (1998). Regulation of cell-type specific expression of lacZ by the 5¢-flanking region of mouse GAD67 gene in the central nervous system of transgenic mice. Eur J Neurosci 10, 989-999.
38. Kawaguchi, Y. (1997). Neostriatal cell subtypes and their functional roles. Neurosci Res 27, 1-8. (Pubitemid 27117091)
39. Kim, O.S., Kim, H.J., Kwak, H.J., et al. (2003). Human act and AR1 sequences differentially regulate murine and human D1A dopamine receptor promoters. Molecules and cells 15, 294-300.
40. Kordower, J.H., Bloch, J., Ma, S., et al. (1999). Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160, 1-16.
41. Kugler, S., Meyn, L., Holzmuller, H., et al. (2001). Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 17, 78-96. (Pubitemid 32113540)
42. Kugler, S., Kilic, E., and Bahr, M. (2003). Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther 10, 337-347. (Pubitemid 36305602)
43. Lee, S.H., Yajima, S., and Mouradian, M.M. (1999). Neural cell line-specific regulatory DNA cassettes harboring the murine D1A dopamine receptor promoter. Neurosci Res 34, 225-234. (Pubitemid 29438703)
44. Li, S.H., Cheng, A.L., Zhou, H., et al. (2002). Interaction of huntington disease protein with transcriptional activator sp1. Mol Cell Biol 22, 1277-1287. (Pubitemid 34150765)
45. Liu, B.H., Wang, X., Ma, Y.X., et al. (2004). CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther 11, 52-60. (Pubitemid 38111388)
46. Liu, B., Wang, S., Brenner, M., et al. (2008). Enhancement of cellspecific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain. J Gene Med 10, 583-592. (Pubitemid 351753527)
47. Lobsiger, C.S., and Cleveland, D.W. (2007). Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10, 1355-1360. (Pubitemid 350014678)
48. Marangos, P.J., Schmechel, D., Parma, A.M., et al. (1979). Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem 33, 319-329. (Pubitemid 9233939)
49. Matamales, M., Bertran-Gonzalez, J., Salomon, L., et al. (2009). Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS ONE 4, e4770.
50. Mazarakis, N.D., Azzouz, M., Rohll, J.B., et al. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121. (Pubitemid 32998823)
51. Mendelson, S.C., Morrison, C.F., Mcallister, J., et al. (1995). Repression of preprotachykinin-A promoter activity is mediated by a proximal promoter element. Neuroscience 65, 837-847.
52. Minowa, M.T., Minowa, T., and Mouradian, M.M. (1993). Activator region analysis of the human D1A dopamine receptor gene. J Biol Chem 268, 23544-23551. (Pubitemid 23328084)
53. Naldini, L., Blömer, U., Gallay, P., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. (Pubitemid 26119138)
54. Nanou, A., and Azzouz, M. (2009). Gene therapy for neurodegenerative diseases based on lentiviral vectors. Prog Brain Res 175, 187-200.
55. Nettelbeck, D.M., Jerome, V., and Muller, R. (1998). A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Therapy 5, 1656-1664. (Pubitemid 29008336)
56. Panganiban, G., and Rubenstein, J.L. (2002). Developmental functions of the Distal-less/Dlx homeobox genes. Development 129, 4371-4386. (Pubitemid 35203722)
57. Paxinos, G., and Watson, C. (2004). The Rat Brain in Stereotaxic Coordinates. (Academic press, New York). 1-474.
58. Portales-Casamar, E., Swanson, D.J., Liu, L., et al. (2010). A regulatory toolbox of MiniPromoters to drive selective expression in the brain. Proc Natl Acad Sci USA 107, 16589-16594.
59. Potter, G.B., Petryniak, M.A., Shevchenko, E., et al. (2009). Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons. Mol Cell Neurosci 40, 167-186.
60. Ravache, M., Weber, C., Merienne, K., and Trottier, Y. (2010). Transcriptional activation of REST by Sp1 in Huntington's disease models. PLoS ONE 5, e14311.
61. Régulier, E., Pereira De Almeida, L., Sommer, B., et al. (2002). Dose-dependent neuroprotective effect of CNTF delivered via tetracycline- regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 13, 1981-1990. (Pubitemid 35341039)
62. Reiner, A., Albin, R.L., Anderson, K.D., et al. (1988). Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA 85, 5733-5737.
63. Runne, H., Regulier, E., Kuhn, A., et al. (2008). Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci 28, 9723-9731.
64. Sakimura, K., Kushiya, E., Takahashi, Y., and Suzuki, Y. (1987). The structure and expression of neuron-specific enolase gene. Gene 60, 103-113. (Pubitemid 18026834)
65. Saxena, S., and Caroni, P. (2011). Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35-48.
66. Schlegel, R., Tralka, T.S., Willingham, M.C., and Pastan, I. (1983). Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32, 639-646.
67. Soboleski, M.R., Oaks, J., and Halford, W.P. (2005). Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB journal 19, 440-442. (Pubitemid 40316543)
68. Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., et al. (2000). The Huntington's disease protein interacts with p53 and CREBbinding protein and represses transcription. Proc Natl Acad Sci USA 97, 6763-6768. (Pubitemid 30412788)
69. Szabo, G., Katarova, Z., Kortvely, E., Greenspan, R.J., et al. (1996). Structure and the promoter region of the mouse gene encoding the 67-kD form of glutamic acid decarboxylase. DNA and Cell Biology 15, 1081-1091. (Pubitemid 27014161)
70. Teschemacher, A.G., Paton, J.F., and Kasparov, S. (2005). Imaging living central neurones using viral gene transfer. Adv Drug Deliv Rev 57, 79-93. (Pubitemid 39424065)
71. Vile, R.G., Diaz, R.M., Miller, N., Mitchell, S., Tuszyanski, A., et al. (1995). Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology 214, 307-313.
72. Wang, Y., Yu, L., and Geller, A.I. (1999). Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system. Hum Gene Ther 10, 1763-1771. (Pubitemid 29357682)
73. Wang, Y., Dye, C.A., Sohal, V., et al. (2010). Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons. J Neurosci 30, 5334-5345.
74. Watson, D.J., Kobinger, G.P., Passini, M.A., et al. (2002). Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 5, 528-537. (Pubitemid 34546082)
75. Wheeler, D.G., and Cooper, E. (2001). Depolarization strongly induces human cytomegalovirus major immediate-early promoter/enhancer activity in neurons. J Biol Chem 276, 31978-31985.
76. Wu, X., Holschen, J., Kennedy, S.C., and Ponder, K.P. (1996). Retroviral vector sequences may interact with some internal promoters and influence expression. Hum Gene Ther 7, 159-171. (Pubitemid 26044835)
77. Xu, R., Janson, C.G., Mastakov, M., et al. (2001). Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther. 8, 1323-1332. (Pubitemid 32834301)
78. Xu, W., Russ, J.L., and Eiden, M.V. (2012). Evaluation of residual promoter activity in gamma-retroviral self-inactivating (SIN) vectors. Mol Ther 20, 84-90.
79. Zala, D., Bensadoun, J.-C., Pereira ee Almeida, L., et al. (2004). Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice. Exp. Neurol. 185, 26-35. (Pubitemid 38010276)
80. Zerucha, T., Stuhmer, T., Hatch, G., et al. (2000). A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain. J Neurosci 20, 709-721. (Pubitemid 30225573)
81. Zhang, L., Adams, J.Y., Billick, E., et al. (2002). Molecular Engineering of a Two-Step Transcription Amplification (TSTA) System for Transgene Delivery in Prostate Cancer. Mol Ther 5, 223-232. (Pubitemid 34211217)
82. Zufferey, R., Dull, T., Mandel, R.J., et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72, 9873-9880. (Pubitemid 28520853)
83. Zufferey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999). Woodschuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73, 2886-2892. (Pubitemid 29135675)